WMSA
Weiss Multi-Strategy Advisers Portfolio holdings
AUM
$3.94B
1-Year Return
29.08%
This Quarter Return
+2.31%
1 Year Return
+29.08%
3 Year Return
+75.24%
5 Year Return
+223.81%
10 Year Return
+334.33%
AUM
$2.01B
AUM Growth
+$144M
(+7.7%)
Cap. Flow
+$101M
Cap. Flow
% of AUM
5.03%
Top 10 Holdings %
Top 10 Hldgs %
18.17%
Holding
636
New
224
Increased
105
Reduced
94
Closed
122
Top Buys
| 1 |
Invitation Homes
INVH
|
+$42.7M |
| 2 |
NYRT
New York REIT, Inc.
NYRT
|
+$38.8M |
| 3 |
Equity Residential
EQR
|
+$28.9M |
| 4 |
McDonald's
MCD
|
+$27.6M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$25.3M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$336M |
| 2 |
Extra Space Storage
EXR
|
+$37.3M |
| 3 |
Boston Properties
BXP
|
+$37.1M |
| 4 |
DRE
Duke Realty Corp.
DRE
|
+$25.9M |
| 5 |
Advance Auto Parts
AAP
|
+$24M |
Sector Composition
| 1 | Real Estate | 27.08% |
| 2 | Consumer Discretionary | 13.33% |
| 3 | Industrials | 10.59% |
| 4 | Energy | 9.17% |
| 5 | Technology | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
AtriCure
ATRC
$1.79B
| $718K | 0.03% |
37,500
| – | – |
|
|
IMMU
352
DELISTED
Immunomedics Inc
IMMU
| $712K | 0.03% |
110,000
| – | – |
|
353
Shake Shack
SHAK
$3.93B
| $701K | 0.03% |
+21,000
| New | +$701K |
|
354
Gilead Sciences
GILD
$144B
| $689K | 0.03% |
10,151
-2,474
| -20% | -$168K |
|
|
WRD
355
DELISTED
WildHorse Resource Development
WRD
| $684K | 0.03% |
55,000
-60,000
| -52% | -$746K |
|
|
DMTX
356
DELISTED
Dimension Therapeutics, Inc
DMTX
| $683K | 0.03% |
390,403
+24,489
| +7% | +$42.8K |
|
|
SYRS
357
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $637K | 0.03% |
4,000
-900
| -18% | -$143K |
|
358
Colgate-Palmolive
CL
$68B
| $620K | 0.02% |
+8,469
| New | +$620K |
|
|
ADAP
359
Adaptimmune Therapeutics
ADAP
$13M
| $606K | 0.02% |
110,000
| – | – |
|
360
Avista
AVA
$2.93B
| $586K | 0.02% |
+15,000
| New | +$586K |
|
361
Alkermes
ALKS
$4.7B
| $585K | 0.02% |
10,000
-2,000
| -17% | -$117K |
|
362
Standard BioTools
LAB
$520M
| $569K | 0.02% |
100,000
| – | – |
|
363
Broadcom
AVGO
$1.58T
| $558K | 0.02% |
25,490
-125,070
| -83% | -$2.74M |
|
364
Pacific Biosciences
PACB
$375M
| $553K | 0.02% |
107,000
| – | – |
|
|
XLRN
365
DELISTED
Acceleron Pharma Inc.
XLRN
| $529K | 0.02% |
20,000
+5,000
| +33% | +$132K |
|
366
Eli Lilly
LLY
$662B
| $515K | 0.02% |
6,126
-12
| -0.2% | -$1.01K |
|
|
WLH
367
DELISTED
WILLIAM LYON HOMES
WLH
| $510K | 0.02% |
24,734
+1,835
| +8% | +$37.8K |
|
|
GRA
368
DELISTED
W.R. Grace & Co.
GRA
| $485K | 0.02% |
6,955
+3,505
| +102% | +$244K |
|
369
Churchill Downs
CHDN
$7.01B
| $477K | 0.02% |
+18,018
| New | +$477K |
|
|
INSY
370
DELISTED
Insys Therapeutics, Inc.
INSY
| $473K | 0.02% |
45,000
+24,000
| +114% | +$252K |
|
371
Exact Sciences
EXAS
$10.2B
| $472K | 0.02% |
20,000
-5,000
| -20% | -$118K |
|
|
ATSG
372
DELISTED
Air Transport Services Group, Inc.
ATSG
| $467K | 0.02% |
+29,069
| New | +$467K |
|
|
RCM
373
DELISTED
R1 RCM Inc. Common Stock
RCM
| $464K | 0.02% |
+150,000
| New | +$464K |
|
|
WNRL
374
DELISTED
Western Refining Logistics, LP
WNRL
| $458K | 0.02% |
18,000
-32,000
| -64% | -$814K |
|
375
Citigroup
C
$176B
| $445K | 0.02% |
+7,442
| New | +$445K |
|